The Dow Jones Industrial Average is within striking distance of all-time high, but more than a third of its components are stuck in the mud.
Even as the blue-chip index nears its all-time high hit in January, 12 of its members are trading in a correction, or 10 percent below recent highs. The worst of the group is Intel, down 20 percent from its all-time high in early June and one of just two Dow stocks negative this quarter.
Other components in a correction include 3M, Goldman Sachs, Walmart and IBM.
Some investors believe that despite the carnage since their respective highs, several blue chips are poised to make a comeback.
Top Blue Chip Stocks To Buy For 2019: Boston Properties, Inc.(BXP)
Advisors' Opinion:- [By Max Byerly]
Earnest Partners LLC raised its holdings in shares of Boston Properties, Inc. (NYSE:BXP) by 4.6% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 187,347 shares of the real estate investment trust’s stock after purchasing an additional 8,269 shares during the period. Earnest Partners LLC owned 0.12% of Boston Properties worth $23,085,000 as of its most recent SEC filing.
- [By Logan Wallace]
Traders purchased shares of Boston Properties (NYSE:BXP) on weakness during trading hours on Friday. $96.18 million flowed into the stock on the tick-up and $15.73 million flowed out of the stock on the tick-down, for a money net flow of $80.45 million into the stock. Of all stocks tracked, Boston Properties had the 13th highest net in-flow for the day. Boston Properties traded down ($0.15) for the day and closed at $117.09
- [By Stephan Byrd]
Lourd Capital LLC purchased a new stake in shares of Boston Properties, Inc. (NYSE:BXP) during the third quarter, HoldingsChannel.com reports. The fund purchased 2,129 shares of the real estate investment trust’s stock, valued at approximately $262,000.
- [By Joseph Griffin]
OppenheimerFunds Inc. lowered its holdings in Boston Properties, Inc. (NYSE:BXP) by 18.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,669 shares of the real estate investment trust’s stock after selling 1,265 shares during the period. OppenheimerFunds Inc.’s holdings in Boston Properties were worth $699,000 at the end of the most recent quarter.
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Boston Properties (BXP)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Logan Wallace]
Boston Properties (NYSE:BXP) insider Bryan J. Koop sold 10,560 shares of the firm’s stock in a transaction on Friday, May 11th. The shares were sold at an average price of $124.27, for a total value of $1,312,291.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Top Blue Chip Stocks To Buy For 2019: Nevro Corp.(NVRO)
Advisors' Opinion:- [By Ethan Ryder]
Nevro (NYSE:NVRO) had its price objective cut by Canaccord Genuity from $110.00 to $102.00 in a note issued to investors on Tuesday, Marketbeat Ratings reports. The brokerage currently has a “buy” rating on the medical equipment provider’s stock. Canaccord Genuity’s price target indicates a potential upside of 34.87% from the stock’s current price.
- [By Brian Feroldi]
Shares of Nevro Corp. (NYSE:NVRO) are falling today, down 13% as of 10:21 a.m. EDT, after an SEC filing revealed that the medical device company's VP of sales has been fired.
- [By Lisa Levin]
Nevro Corp. (NASDAQ: NVRO) shares dropped 14 percent to $79.35 after reporting wider-than-expected Q1 loss.
Shares of Hertz Global Holdings, Inc. (NYSE: HTZ) were down 11 percent to $19.77 after the company reported a wider-than-expected loss for its first quarter.
- [By Ethan Ryder]
Wells Fargo & Company MN lessened its holdings in Nevro (NYSE:NVRO) by 5.2% during the first quarter, HoldingsChannel.com reports. The fund owned 823,579 shares of the medical equipment provider’s stock after selling 45,510 shares during the quarter. Wells Fargo & Company MN’s holdings in Nevro were worth $71,378,000 at the end of the most recent quarter.
- [By Paul Ausick]
Nevro Corp. (NYSE: NVRO) traded down about 19% Friday and posted a new 52-week low of $54.87 after closing Thursday at $68.04. The stock’s 52-week high is $94.34. Volume totaled around 5.7 million, close to 15 times the daily average. The company had no specific news.
Top Blue Chip Stocks To Buy For 2019: Eaton Vance Limited Duration Income Fund(EVV)
Advisors' Opinion:- [By Logan Wallace]
Eaton Vance Ltd Duration Income Fund (NYSEAMERICAN:EVV) was the recipient of a large increase in short interest in September. As of September 14th, there was short interest totalling 61,700 shares, an increase of 154.4% from the August 31st total of 24,249 shares. Currently, 0.1% of the company’s shares are short sold. Based on an average trading volume of 199,358 shares, the short-interest ratio is currently 0.3 days.
Top Blue Chip Stocks To Buy For 2019: Brown-Forman Corporation (BF-A)
Advisors' Opinion:- [By Chris Hill]
In this episode of MarketFoolery, host Chris Hill talks with Motley Fool analyst Emily Flippen about the market's biggest news. Abercrombie & Fitch (NYSE:ANF) is up huge on a deeply lame quarter. Was there some gold hidden between the lines, or was this yet another case of bad results beating terrible expectations? Dollar Tree (NASDAQ:DLTR) saw a little pop after its earnings report, but more interestingly, the company announced some big changes regarding its Family Dollar acquisition. Brown-Forman (NYSE:BF-A) (NYSE:BF-B) fell about 7% after reporting earnings. Could it be that they just have too many brands? Chinese automaker NIO (NYSE:NIO) tanked, but investors probably want to resist the "China is too scary" narrative that's cropping up as a result. Tune in to find out more.
- [By Dan Caplinger]
Wednesday was a bad day on Wall Street, as most major indexes finished lower. Small-cap stocks were hit harder than their large-cap counterparts, due in part to readings on the U.S. economy that signaled the possibility of a slowdown in the future. Moreover, downward pressure from some high-profile players weighed on overall market sentiment. NIO (NYSE:NIO), Brown-Forman (NYSE:BF-A) (NYSE:BF-B), and Sarepta Therapeutics (NASDAQ:SRPT) were among the worst performers. Here's why they did so poorly.
- [By Rich Duprey]
Tariffs have long weighed on shares of whiskey distiller Brown-Forman (NYSE:BF-A) (NYSE:BF-B), which exports more than half of its spirits to international markets, led by its best-selling Jack Daniel's whiskey. In its most recently-reported quarter, net sales were flat at $910 million due to tariff-related inventory reductions. That followed a big sales increase in the first quarter of fiscal 2019, when customers were racing to stock up ahead of the imposition of retaliatory tariffs by Europe.
- [By Dan Caplinger]
The stock market did exceptionally well on Wednesday, with the Dow Jones Industrial Average climbing more than 300 points and certain other major benchmarks reaching record heights. In general, investors remained upbeat about the prospects for the U.S. economy overcoming any trade-related tensions and continuing to grow, riding the wave of lower corporate tax rates to boost profits. Yet even with a favorable mood in the market overall, some companies had bad news that sent their shares sharply lower. Ambarella (NASDAQ:AMBA), YY (NASDAQ:YY), and Brown-Forman (NYSE:BF-A) (NYSE:BF-B) were among the worst performers on the day. Here's why they did so poorly.
- [By Rich Duprey, John Bromels, and Anders Bylund]
Coupled with a solid business that points to their being able to raise their payout every year for years to come, Cintas (NASDAQ:CTAS), A.O. Smith (NYSE:AOS), and Brown-Forman (NYSE:BF-A)(NYSE:BF-B) are three Dividend Aristocrats that you can buy once for your portfolio and hold on to forever.
Top Blue Chip Stocks To Buy For 2019: Movado Group Inc.(MOV)
Advisors' Opinion:- [By Motley Fool Transcribing]
Movado Group (NYSE:MOV) Q2 2019 Earnings Conference CallAug. 29, 2018 9:00 a.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Lisa Levin] Gainers Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study. Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing. ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating. Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook. TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy. Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday. Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital. Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00. SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday. Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40. Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance. Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins. Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr
- [By Logan Wallace]
Shares of Movado Group, Inc (NYSE:MOV) have earned a consensus rating of “Hold” from the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation, one has given a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $39.00.
No comments:
Post a Comment